Zeria Pharmaceutical Co., Ltd. - Product Pipeline Review - 2015

Date: September 30, 2015
Pages: 38
Price:
US$ 1,500.00 US$ 1,200.00
Offer valid until December 31, 2016!
License [?]:
Publisher: Global Markets Direct
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: ZED8F974565EN
Leaflet:

Download PDF Leaflet

Zeria Pharmaceutical Co., Ltd. - Product Pipeline Review - 2015

SUMMARY

Global Markets Direct’s, ‘Zeria Pharmaceutical Co., Ltd. - Product Pipeline Review - 2015’, provides an overview of the Zeria Pharmaceutical Co., Ltd.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Zeria Pharmaceutical Co., Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

SCOPE
  • The report provides brief overview of Zeria Pharmaceutical Co., Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Zeria Pharmaceutical Co., Ltd.’s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Zeria Pharmaceutical Co., Ltd.’s pipeline products
REASONS TO BUY
  • Evaluate Zeria Pharmaceutical Co., Ltd.’s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Zeria Pharmaceutical Co., Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Zeria Pharmaceutical Co., Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Zeria Pharmaceutical Co., Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Zeria Pharmaceutical Co., Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Zeria Pharmaceutical Co., Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues
Zeria Pharmaceutical Co., Ltd. Snapshot
Zeria Pharmaceutical Co., Ltd. Overview
Key Information
Key Facts
Zeria Pharmaceutical Co., Ltd. - Research and Development Overview
Key Therapeutic Areas
Zeria Pharmaceutical Co., Ltd. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Pipeline Products - Out-Licensed Products
Out-Licensed Products/Combination Treatment Modalities
Zeria Pharmaceutical Co., Ltd. - Pipeline Products Glance
Zeria Pharmaceutical Co., Ltd. - Late Stage Pipeline Products
Phase III Products/Combination Treatment Modalities
Zeria Pharmaceutical Co., Ltd. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Zeria Pharmaceutical Co., Ltd. - Drug Profiles
acotiamide hydrochloride
Product Description
Mechanism of Action
R&D Progress
polaprezinc
Product Description
Mechanism of Action
R&D Progress
Z-100
Product Description
Mechanism of Action
R&D Progress
ZOSA-0
Product Description
Mechanism of Action
R&D Progress
E-3710
Product Description
Mechanism of Action
R&D Progress
Z-360
Product Description
Mechanism of Action
R&D Progress
ferric carboxymaltose
Product Description
Mechanism of Action
R&D Progress
Zeria Pharmaceutical Co., Ltd. - Pipeline Analysis
Zeria Pharmaceutical Co., Ltd. - Pipeline Products by Target
Zeria Pharmaceutical Co., Ltd. - Pipeline Products by Route of Administration
Zeria Pharmaceutical Co., Ltd. - Pipeline Products by Molecule Type
Zeria Pharmaceutical Co., Ltd. - Pipeline Products by Mechanism of Action
Zeria Pharmaceutical Co., Ltd. - Recent Pipeline Updates
Zeria Pharmaceutical Co., Ltd. - Dormant Projects
Zeria Pharmaceutical Co., Ltd. - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
acotiamide hydrochloride
Zeria Pharmaceutical Co., Ltd. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

LIST OF TABLES

Zeria Pharmaceutical Co., Ltd., Key Information
Zeria Pharmaceutical Co., Ltd., Key Facts
Zeria Pharmaceutical Co., Ltd. - Pipeline by Indication, 2015
Zeria Pharmaceutical Co., Ltd. - Pipeline by Stage of Development, 2015
Zeria Pharmaceutical Co., Ltd. - Monotherapy Products in Pipeline, 2015
Zeria Pharmaceutical Co., Ltd. - Partnered Products in Pipeline, 2015
Zeria Pharmaceutical Co., Ltd. - Partnered Products/ Combination Treatment Modalities, 2015
Zeria Pharmaceutical Co., Ltd. - Out-Licensed Products in Pipeline, 2015
Zeria Pharmaceutical Co., Ltd. - Out-Licensed Products/ Combination Treatment Modalities, 2015
Zeria Pharmaceutical Co., Ltd. - Phase III, 2015
Zeria Pharmaceutical Co., Ltd. - Phase II, 2015
Zeria Pharmaceutical Co., Ltd. - Phase I, 2015
Zeria Pharmaceutical Co., Ltd. - Pipeline by Target, 2015
Zeria Pharmaceutical Co., Ltd. - Pipeline by Route of Administration, 2015
Zeria Pharmaceutical Co., Ltd. - Pipeline by Molecule Type, 2015
Zeria Pharmaceutical Co., Ltd. - Pipeline Products by Mechanism of Action, 2015
Zeria Pharmaceutical Co., Ltd. - Recent Pipeline Updates, 2015
Zeria Pharmaceutical Co., Ltd. - Dormant Developmental Projects,2015
Zeria Pharmaceutical Co., Ltd. - Discontinued Pipeline Products, 2015
Zeria Pharmaceutical Co., Ltd., Other Locations
Zeria Pharmaceutical Co., Ltd., Subsidiaries

LIST OF FIGURES

Zeria Pharmaceutical Co., Ltd. - Pipeline by Top 10 Indication, 2015
Zeria Pharmaceutical Co., Ltd. - Pipeline by Stage of Development, 2015
Zeria Pharmaceutical Co., Ltd. - Monotherapy Products in Pipeline, 2015
Zeria Pharmaceutical Co., Ltd. - Partnered Products in Pipeline, 2015
Zeria Pharmaceutical Co., Ltd. - Out-Licensed Products in Pipeline, 2015
Zeria Pharmaceutical Co., Ltd. - Pipeline by Top 10 Target, 2015
Zeria Pharmaceutical Co., Ltd. - Pipeline by Top 10 Route of Administration, 2015
Zeria Pharmaceutical Co., Ltd. - Pipeline by Top 10 Molecule Type, 2015
Zeria Pharmaceutical Co., Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2015
Skip to top


Ask Your Question

Zeria Pharmaceutical Co., Ltd. - Product Pipeline Review - 2015
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: